Print

EV02 (EuroVacc 02)

phase I clinical trial of novel investigational vaccines comprising DNA-HIV-C and NYVAC-HIV-C for the prevention of HIV infection

Trial Details:

I/II Completed
European Vaccine Effort June 01, 2007
NYVAC-C,DNA-C Pox gag, pol, nef and env C; DNA Nef; Gag; Env; Pol C 97CN54
DNA-C DNA
NYVAC-C Viral Vector - Pox
Switzerland, United Kingdom
NCT00490074
http://clinicaltrials.gov/ct2/show/NCT00490074?term=eurovacc&rank=1